Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Lymphoma, Large B-Cell, Diffuse 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma 14Lymphoma, Non-Hodgkin 10Lymphoma, Follicular 8Lymphoma, B-Cell 8Lymphoma, Mantle-Cell 7Burkitt Lymphoma 7Rhabdomyosarcoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Recurrence 5Leukemia 5Immunoblastic Lymphadenopathy 5Lymphoma, T-Cell, Peripheral 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Lymphocytic, Chronic, B-Cell 4Sarcoma, Ewing 3Lymphoma, Primary Effusion 3Sarcoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Plasmablastic Lymphoma 2Osteosarcoma 2Neuroblastoma 2Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Hodgkin Disease 2Enteropathy-Associated T-Cell Lymphoma 2

Interventions

Temozolomide 23Radiotherapy 15Radiation 7Bevacizumab 6temsirolimus 5Sirolimus 5Radiotherapy, Conformal 5Erlotinib Hydrochloride 5Carmustine 5Carboplatin 5Radiotherapy, Intensity-Modulated 4Everolimus 4Vorinostat 3Irinotecan 3veliparib 2tipifarnib 2plerixafor 2pembrolizumab 2atezolizumab 2Surgical Procedures, Operative 2Sorafenib 2Gefitinib 2Fluorodeoxyglucose F18 2Cilengitide 2Chemotherapy, Adjuvant 2vatalanib 1vandetanib 1terameprocol 1tandutinib 1romidepsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Gliosarcoma × Vincristine × Clear all
NCT01837862 2024-07-05

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

Northwell Health

Phase 1/2 Completed
36 enrolled
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Gliosarcoma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡